Prognostic relevance of CD20 expression in peripheral T-cell lymphomas: a multi-center retrospective study

Leuk Lymphoma. 2016;57(4):961-4. doi: 10.3109/10428194.2015.1083097. Epub 2015 Dec 23.

Affiliations

¹ a Department of Hematology & Oncology , The University of Tokyo , Tokyo , Japan ;
² b Department of Hematology , NTT Medical Center Tokyo , Tokyo , Japan ;
³ c Department of Hematology , Tokyo Women's Medical University , Tokyo , Japan ;
⁴ d Department of Medical Oncology , Tokyo Metropolitan Cancer and Infection diseases Center Komagome Hospital , Tokyo , Japan.

PMID: 26366623
DOI: 10.3109/10428194.2015.1083097

No abstract available

Publication types

Letter
Multicenter Study

MeSH terms

Antigens, CD20 / genetics
Antigens, CD20 / metabolism*
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Biopsy
Cyclophosphamide / therapeutic use
Doxorubicin / therapeutic use
Flow Cytometry
Gene Expression
Humans
Kaplan-Meier Estimate
Lymphoma, T-Cell, Peripheral / diagnosis
Lymphoma, T-Cell, Peripheral / drug therapy
Lymphoma, T-Cell, Peripheral / metabolism*
Lymphoma, T-Cell, Peripheral / mortality*
Prednisone / therapeutic use
Prognosis
Retrospective Studies
Treatment Outcome
Vincristine / therapeutic use

Substances

Antigens, CD20
Vincristine
Doxorubicin
Cyclophosphamide
Prednisone

Supplementary concepts

CHOP protocol